ASCEND BY NTHRYS
Research Abroad Products

Immunotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 25–36 of 200 project topics
Sandwich Immunoassay Biomarker Detection Platform
A commercialized sandwich immunoassay system with proprietary antibody reagents and digital image analysis for detecting emerging disease biomarkers in blood and serum samples. Revenue is generated through reagent kit sales, licensing of assay protocols, and white-label partnerships with clinical laboratory networks.
Immunoassay Technology Commercial Development Click to view more details →
Competitive Immunoassay Reagent Supply Chain Platform
A B2B marketplace and inventory management platform connecting small-to-medium diagnostic labs with vetted suppliers of high-quality competitive immunoassay reagents and calibrators. Business value is derived from transaction commissions, subscription fees for supply chain visibility, and data analytics on reagent performance trends.
Immunoassay Technology Commercial Development Click to view more details →
Time-Resolved Fluorescence Immunoassay Commercial Kit
A ready-to-use commercial immunoassay kit utilizing time-resolved fluorescence technology for ultra-sensitive detection of pharmaceutical drug levels and therapeutic drug monitoring. Revenue is generated through high-margin kit sales to hospital pharmacies, clinical labs, and pharmaceutical CROs conducting TDM programs.
Immunoassay Technology Commercial Development Click to view more details →
Immunoassay Data Analytics and Quality Assurance Engine
A sophisticated SaaS analytics platform that aggregates immunoassay results, performs statistical quality control, detects assay drift, and generates compliance reports for ISO 15189 accreditation. It monetizes through subscription licensing based on test volume, premium predictive maintenance modules, and integration API fees.
Immunoassay Technology Commercial Development Click to view more details →
Enzyme-Linked Immunosorbent Assay Validation Services
A professional services offering providing end-to-end ELISA assay development, validation, and commercialization support for biotech and pharmaceutical companies bringing new diagnostics to market. Revenue derives from project-based consulting fees, equity stakes in client companies, and ongoing royalties on commercialized assays.
Immunoassay Technology Commercial Development Click to view more details →
Immunoassay Instrumentation Integration and Middleware Software
A universal middleware software platform that integrates disparate immunoassay instruments, analyzers, and LIS systems into a unified laboratory information system with standardized data formats. The business model includes licensing fees per connected device, annual maintenance contracts, and premium modules for advanced reporting and data interoperability.
Immunoassay Technology Commercial Development Click to view more details →
Bispecific Antibody Design Software Platform Suite
Cloud-based computational platform that automates the design, optimization, and validation of bispecific antibody constructs using AI-driven modeling algorithms. Reduces development time by 60% and enables pharma companies to bring bispecific therapeutics to market faster, generating recurring SaaS licensing revenue.
Immunotechnology Bispecific Antibody Platforms Click to view more details →
Therapeutic Bispecific Antibody Manufacturing Service
Contract manufacturing organization specializing in GMP-scale production of bispecific antibodies using proprietary dual-chain and single-chain technologies. Creates high-margin recurring revenue through manufacturing fees and royalties on clinical and commercial products.
Immunotechnology Bispecific Antibody Platforms Click to view more details →
Bispecific Target Pairing Database and Analytics Tool
Proprietary database and software tool that identifies optimal antigen combinations for bispecific antibody development based on efficacy and safety data. Monetizes through tiered subscription licenses to biotech and pharma R&D teams seeking faster target validation.
Immunotechnology Bispecific Antibody Platforms Click to view more details →
Tumor-Engaging Bispecific Antibody Assay Platform
High-throughput automated assay platform for functional screening and characterization of tumor-targeting bispecific antibodies in development. Delivers revenue through assay kit sales, contract testing services, and platform licensing to pharmaceutical development centers.
Immunotechnology Bispecific Antibody Platforms Click to view more details →
Immune Checkpoint Bispecific Antibody Technology Licensing
Proprietary platform technology enabling rapid development of immune checkpoint-engaging bispecific antibodies with enhanced T-cell activation profiles. Generates revenue through upfront licensing fees, milestone payments, and royalties on commercial sales.
Immunotechnology Bispecific Antibody Platforms Click to view more details →
Bispecific Antibody Manufacturing Process Optimization Software
Real-time process monitoring and control software optimizing cell culture, purification, and quality metrics for bispecific antibody production. Reduces manufacturing costs by 40% and waste by 35%, capturing value through SaaS fees and process improvement contracts.
Immunotechnology Bispecific Antibody Platforms Click to view more details →